## 5093 Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices

Name of Committee: National Cancer Institute Special Emphasis Panel, Innovative Technologies Development.

Date: March 10–11, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Jeffrey E. DeClue, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8059, Bethesda, MD 20892–8329, 301–496–7904, decluej@mail.nih.gov.

Name of Committee: National Cancer Institute Special Emphasis Panel, EDRN Biomarker Development Labs (U01).

Date: March 10–11, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications.

Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.

Contact Person: Sherwood Githens, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd. Room 8146, Bethesda, MD 20892, 301–435–1822, githenss@mail.nih.gov.

Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Anticancer Agents.

Date: March 24–26, 2010. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals.

Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.

Contact Person: Joyce C. Pegues, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, NIH National Cancer Institute, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892–8329, 301–594–1286, peguesj@mail.nih.gov.

Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Nanotechnology Platform Partnerships.

Date: March 31–April 1, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications.

Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852.

Contact Person: Savvas C Makrides, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 8053, Bethesda, MD 20892, 301–496–7421, makridessc@mail.nih.gov.

Name of Committee: National Cancer Institute Special Emphasis Panel, Small Grants Program for Cancer Epidemiology.

Date: April 15–16, 2010. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.

Contact Person: Joyce C. Pegues, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892–8329, 301–594–1286, peguesj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: January 25, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010–2030 Filed 1–29–10; 8:45 am]

**BILLING CODE 4140–01–P**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**National Institutes of Health**

**National Institute of Neurological Disorders and Stroke; Notice of Closed**  **Meetings**

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group, Neurological Sciences and Disorders B.

Date: February 25–26, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications.

Place: US Grant Hotel, 326 Broadway, San Diego, CA 92101.

Contact Person: Ernest W Lyons, PhD, Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, 301–
496–4056.

Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review, Group Neurological Sciences and Disorders A.

Date: March 3, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications.

Place: Argonaut Hotel, 495 Jefferson Street, San Francisco, CA 94109.

Contact Person: Richard D. Crosland, PhD, Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, 301–496–9223. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)

Dated: January 25, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010–1932 Filed 1–29–10; 8:45 am]

**BILLING CODE 4140–01–P**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**Agency for Healthcare Research and Quality** 

**Notice of Meeting**

In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting.

A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as-needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise.

Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b (c)(6). Grant applications for the ARRA: Limited Competition ‘‘Electronic Data Methods ’’ (U13) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory


## 5094 Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices

disclosure under the above-cited
statutes.

SEP Meeting on: ARRA: Limited Competition ‘‘Electronic Data Methods ’’ (U13).

Date: February 26, 2010 (Open on February 26 from 8 a.m. to 8:15 a.m. and closed for the remainder of the meeting).

Place: Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, Forest Glen Conference Room, Bethesda, Maryland 20852.

Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427–1554.

Agenda items for this meeting are subject to change as priorities dictate.

Dated: January 21, 2010. Carolyn M. Clancy,

Director.
[FR Doc. 2010–1902 Filed 1–29–10; 8:45 am]

**BILLING CODE 4160–90–M**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**Agency for Healthcare Research and Quality** 

**Notice of Meeting**

In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting.

A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members ofthe Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise.

Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the Transforming Primary Care (Ri 8) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited statutes.

SEP Meeting on: Transforming Primary Care (Ri 8).

Date: March 9–10, 2010 (Open on March 9 from 8:30 a.m. to 8:45 a.m. and closed for the remainder of the meeting).

Place: Doubletree Hotel & Executive Meeting Center, 8120 Wisconsin Avenue, Conference Room TBD, Bethesda, Maryland
20852.

Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the nonconfidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427–1554.



### Agenda items for this meeting are subject to change as priorities dictate.

Dated: January 25, 2010. Carol M. Clancy,

Director.
[FR Doc. 2010–1900 Filed 1–29–10; 8:45 am]

**BILLING CODE 4160–90–M**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**Centers for Disease Control and Prevention** 

**Advisory Committee on Immunization Practices (ACIP)** 

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee:

Times and Dates 8 a.m.–6 p.m., February 24, 2010. 8 a.m.–3 p.m., February 25, 2010.

Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30333.

Status: Open to the public, limited only by the space available.

Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines.

Matters To Be Discussed: The agenda will include discussions on; Human Papillomavirus (HPV) Vaccines; 13–Valent Pneumococcal Conjugate Vaccine; Influenza Vaccines; Rotavirus Vaccines; Vaccine Supply Update; Meningococcal Vaccines; Evidence Based Recommendations; Hepatitis B vaccination for diabetics.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Antonette Hill, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., Mailstop E–05, Atlanta, Georgia 30333, telephone (404)639–8836, fax (404)639–8905.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR.

Dated: January 22, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2010–2043 Filed 1–29–10; 8:45 am]

**BILLING CODE 4160–18–P**



### DEPARTMENT OF HEALTH AND **HUMAN SERVICES**

**Health Resources and Services Administration** 

**Privacy Act of 1974; Report of an Altered System of Records** 

**AGENCY** 

### : Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS).

**ACTION** 

### : Notice of an Altered System of Records (SOR).

**SUMMARY** 

### : In accordance with the requirements of the Privacy Act of 1974, the Health Resources and Services Administration (HRSA) is publishing notice of a proposal to alter the system of records for the Health Education Assistance On-Line Processing System (HOPS), 09–15–0044.

The purposes of these alterations are to update the location of this system and the system manager, to modify routine use number 6, correct typographical errors, and to add routine use number 17 related to notification of breaches in security or confidentiality of records maintained in the system. In addition, the section for Policies and Practices for Storing, Retrieving, Accessing, Retaining and Disposing of Records in the System was updated. The ‘‘Authority for Maintenance of System’’ provision has been modified to reference Section 702 of the Public Health Service Act [42 U.S.C. Section 292a], as amended, and to add the Debt Collection Improvement Act (31 U.S.C. Sections 3701 and 3711– 3720E). Lastly, the ‘‘Disclosure to Consumer Reporting Agencies ’’ provision was modified to reference the definition of a ‘‘ consumer reporting